Synapticure Funding: $40M Raised, Series A (2024)

Synapticure funding overview

Synapticure is based in Chicago, IL. Synapticure has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in November 2024. The round record for Synapticure runs through 2024; nothing later has been disclosed. Investors on record include B Capital, GV, CommonSpirit Health, CVS Health Ventures, RA Capital Management, Nexus NeuroTech Ventures and 6 others. 12 distinct backers are named across the disclosed rounds.

Synapticure at a glance

Total raised: $40M
Latest round: Series A
Latest round date: November 2024
Headquarters: Chicago, IL
Notable investors: B Capital, GV, CommonSpirit Health, CVS Health Ventures, RA Capital Management, Nexus NeuroTech Ventures, Optum Ventures, Rock Health Capital

Frequently asked about Synapticure funding

How much has Synapticure raised?: Synapticure has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Synapticure?: B Capital, GV, CommonSpirit Health, CVS Health Ventures, RA Capital Management, Nexus NeuroTech Ventures are named among the investors backing Synapticure.
What was the latest Synapticure funding round?: The most recent disclosed round is a Series A, announced in November 2024.
Where is Synapticure based?: Synapticure is based in Chicago, IL.
When did Synapticure last raise?: The last disclosed Synapticure round closed in November 2024 at Series A.

Synapticure totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Chicago below to benchmark round size and investor mix.

Synapticure Funding: $40M Raised, Series A (2024)

Synapticure funding overview

Synapticure at a glance

Frequently asked about Synapticure funding

Companies related to Synapticure (36)

Browse related funding lists (7)